The Lancet, 400(10350), 431-440. ELSEVIER SCIENCE INC 2022, ' Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01) : a randomised, factorial, multicentre, open-label, phase 3 study ', The Lancet, vol. 400, no. 10350, pp. 431-440 . https://doi.org/10.1016/S0140-6736(22)01246-6